Alpha Financial Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,993
Closed -$247K 134
2024
Q2
$247K Sell
1,993
-187
-9% -$24.1K 0.21% 58
2024
Q1
$288K Sell
2,180
-361
-14% -$44.5K 0.26% 46
2023
Q4
$277K Sell
2,541
-446
-15% -$46.3K 0.27% 48
2023
Q3
$308K Sell
2,987
-36
-1% -$3.88K 0.36% 49
2023
Q2
$349K Buy
3,023
+447
+17% +$50.8K 0.37% 52
2023
Q1
$274K Buy
2,576
+490
+23% +$52.9K 0.31% 68
2022
Q4
$231K Buy
+2,086
New +$213K 0.28% 75

Other funds holding MRK

Alpha Financial Partners's MRK Position: Q3 2024 in Review

Alpha Financial Partners sold out of Merck (MRK) in Q3 2024, closing a stake of 1,993 shares — an estimated $247K sold.

Alpha Financial Partners first reported a position in MRK in Q4 2022 and held it in 7 quarters. The position peaked at $349K in Q2 2023. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Alpha Financial Partners reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
  • Alpha Financial Partners sold 1,993 Merck shares in Q3 2024, an estimated $247K.
  • Alpha Financial Partners first reported a position in Merck in Q4 2022 and held it in 7 quarters.
  • Alpha Financial Partners's Merck position peaked at $349K in Q2 2023.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Alpha Financial Partners's 13F filing for Q3 2024, filed 24 Oct 2024.